Great news｜EuroPCR 2020 releases DEFINITION Ⅱ research
The DEFINITION II study is a prospective, international multi-center, randomized controlled trial initiated
by Professor Chen Shaoliang. A total of 49 centers participated. The main purpose of the trial was to compare
the eefficacy of the dual stent surgery and provisional surgery in patients with ...
The Department of Cardiovascular Medicine, Nanjing First Hospital, under the leadership of the subject leader Professor Chen Shaoliang, has sharpened its sword for ten years and forged ahead; in April 2020, it was listed as the
The Department of Cardiovascular Medicine, Nanjing First Hospital was established in 1958. After decades of
hard work by several generations of cardiovascular experts, it has developed into a unity of medicine,
teaching and research, with a complete echelon of talents, strong technical force and medica...
“Fight the Pandemic Together-CSC is In the Action”——CSC&Malaysia
On March 26th, the team led by the Fellow Yaling Han of the Northern Theater General Hospital of the Chinese
Medical Association Cardiovascular Branch (CSC), President Shaoliang Chen from Nanjing First Hospital, and
Doctor Junjie Zhang and other team members, together with Professor ...